(Q33867088)

29 July 2017

title

Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas (English)

1 reference

29 July 2017

2

Chen-Yang Shen

1 reference

29 July 2017

Yao-Chi Liu

1

1 reference

29 July 2017

Hurng-Sheng Wu

3

1 reference

29 July 2017

Tsai-Yuan Hsieh

4

1 reference

29 July 2017

De-Chuan Chan

5

1 reference

29 July 2017

Cheng-Jueng Chen

6

1 reference

29 July 2017

Jyh-Cherng Yu

7

1 reference

29 July 2017

Cheng-Ping Yu

8

1 reference

29 July 2017

Horng-Jyh Harn

9

1 reference

29 July 2017

Peng-Jen Chen

10

1 reference

29 July 2017

Chung-Bao Hsieh

11

1 reference

29 July 2017

Teng-Wei Chen

12

1 reference

29 July 2017

Huan-Mieng Hsu

13

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

World Journal of Gastroenterology

29 July 2017

published in

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

14

1 reference

29 July 2017

page(s)

2168-2173

1 reference

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells--regulation by Rho, Rac and Rab small G proteins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Inactivation of the E-cadherin-mediated cell adhesion system in human cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

E-cadherin germline mutations in familial gastric cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Adhesion molecules: novel molecular tools in tumor pathology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

E-cadherin gene mutations provide clues to diffuse type gastric carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Mechanisms of tumor invasion: evidence from in vivo observations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Cadherins: a molecular family important in selective cell-cell adhesion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Cadherin cell adhesion receptors as a morphogenetic regulator

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Metabolic aspects of peroxisomal beta-oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Variations in body composition and plasma lipids in response to a high-carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Persistent hyperaminotransferasemia resolving after weight reduction in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Use of sibutramine to treat obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Use of ursodeoxycholic acid in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Mutations of the human E-cadherin (CDH1) gene.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

29 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I14.2161

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087641

Decreased expression of E-cadherin in the progression of rat prostatic cancer

29 October 2018

1 reference

12 December 2020

E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration

1 reference

12 December 2020

Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer

1 reference

12 December 2020

Identification of germ-line E-cadherin mutations in gastric cancer families of European origin

1 reference

12 December 2020

An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer

1 reference

12 December 2020

E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas

1 reference

12 December 2020

Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer

1 reference

12 December 2020

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer

1 reference

12 December 2020

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

1 reference

12 December 2020

E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas

1 reference

12 December 2020

Expression of E- and P-cadherin in gastric carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I14.2161

1 reference

29 July 2017

1 reference

29 July 2017

1 reference